{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:23:34Z","timestamp":1780917814003,"version":"3.54.1"},"reference-count":40,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"unspecified","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National Center for Inheritance and Innovation of Traditional Chinese Medicine, Pudong Famous Traditional Chinese Medicine Training Plan of Shanghai","award":["PWRzm2020-02"],"award-info":[{"award-number":["PWRzm2020-02"]}]},{"name":"High level key disciplines of Medicine of National Administration of Traditional Chinese Medicine","award":["ZYYzDXK-2023060"],"award-info":[{"award-number":["ZYYzDXK-2023060"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,7,12]]},"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Acupuncture is widely used for metabolic-associated fatty liver disease (MAFLD) treatment; however, the clinical efficacy has not been confirmed due to the lack of high-level evidence-based clinical practice. The purpose of this study is to design a research protocol that will be used to determine the efficacy of acupuncture versus sham acupuncture (SHA) for MAFLD treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>This will be a multicentre, randomised and sham-controlled trial. Ninety-eight participants with MAFLD will be enrolled in this trial. Participants will be randomly assigned in a 1:1 ratio to receive acupuncture or SHA for 12 weeks. The primary outcome is the rate of patients with a 30% relative decline in liver fat after 12 weeks of treatment in MRI-proton density fat fraction (MRI-PDFF), which will be obtained by quantitative chemical shift imaging such as the multipoint Dixon method at 0, 12 and 24 weeks. Secondary outcomes include the changes in the relative liver fat content measured by MRI-PDFF, magnetic resonance elastography, liver function, lipid metabolism, homeostatic model assessment for insulin resistance (HOMA-IR) and serum high sensitivity C reactive protein, which will be obtained at 0, 6, 12 and 24 weeks. Body measurement indicators (body mass index, waist circumference, hip circumference and waist-to-hip ratio) will be obtained at 0, 3, 6, 9, 12 and 24 weeks. The alteration in the gut microbiota composition and its metabolism will be assessed by 16S ribosomal RNA sequencing and liquid chromatography-mass spectrometry at 0 and 12 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>This study protocol has been approved by the ethics committee of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine (2023-1347-114-01). The results of this study will be published in a peer-reviewed journal and presented at academic conferences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>ChiCTR2300075701.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2023-081293","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T05:27:52Z","timestamp":1726464472000},"page":"e081293","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Investigating the efficacy of acupuncture in treating patients with metabolic-associated fatty liver disease: a protocol for a randomised controlled clinical trial"],"prefix":"10.1136","volume":"14","author":[{"given":"Lihong","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jielu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6754-143X","authenticated-orcid":false,"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"2024091522265339000_14.9.e081293.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.05.044"},{"key":"2024091522265339000_14.9.e081293.2","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin Sci"},{"key":"2024091522265339000_14.9.e081293.3","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-020-01210-0"},{"key":"2024091522265339000_14.9.e081293.4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.numecd.2023.01.013","article-title":"Comparison of cardiovascular mortality between MAFLD and NAFLD: A cohort study","volume":"33","author":"Yoo","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2024091522265339000_14.9.e081293.5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2023.100810","article-title":"Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma","volume":"5","author":"Song","year":"2023","journal-title":"JHEP Rep"},{"key":"2024091522265339000_14.9.e081293.6","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/hepr.12656","article-title":"The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment","volume":"46","author":"Ballestri","year":"2016","journal-title":"Hepatol Res"},{"key":"2024091522265339000_14.9.e081293.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.021"},{"key":"2024091522265339000_14.9.e081293.8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cgh.2018.08.065","article-title":"Emerging role of the gut microbiome in nonalcoholic fatty liver disease: from composition to function","volume":"17","author":"Sharpton","year":"2019","journal-title":"CLIN GASTROENTEROL Hepatol"},{"key":"2024091522265339000_14.9.e081293.9","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1111\/liv.15024","article-title":"Diet and exercise in NAFLD\/NASH: Beyond the obvious","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver Int"},{"key":"2024091522265339000_14.9.e081293.10","first-page":"129","article-title":"Electroacupuncture combined with lifestyle control on obese nonalcoholic fatty liver disease: a randomized controlled trial","volume":"40","author":"Dong","year":"2020","journal-title":"Chin Acupunct Moxibust"},{"key":"2024091522265339000_14.9.e081293.11","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.3748\/wjg.v26.i34.5118","article-title":"Acupuncture improved lipid metabolism by regulating intestinal absorption in mice","volume":"26","author":"Han","year":"2020","journal-title":"World J Gastroenterol"},{"key":"2024091522265339000_14.9.e081293.12","doi-asserted-by":"crossref","first-page":"1131092","DOI":"10.3389\/fmicb.2023.1131092","article-title":"Acupuncture improved hepatic steatosis in HFD-induced NAFLD rats by regulating intestinal microbiota","volume":"14","author":"Wang","year":"2023","journal-title":"Front Microbiol"},{"key":"2024091522265339000_14.9.e081293.13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1353\/hpu.2011.0002","article-title":"Trends in the use of complementary and alternative medicine in the United States: 2002-2007","volume":"22","author":"Su","year":"2011","journal-title":"J Health Care Poor Underserved"},{"key":"2024091522265339000_14.9.e081293.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"2024091522265339000_14.9.e081293.15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"key":"2024091522265339000_14.9.e081293.16","unstructured":"Zhao W , Xv E , Wang X , et al . n.d. Traditional Chinese medicine guidelines for the diagnosis and treatment of non-alcoholic fatty liver disease (in Chinese). J Clin 39:1041\u20138. doi:10.3969\/j.issn.1001-5256.2003.05.007"},{"key":"2024091522265339000_14.9.e081293.17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.5603\/CJ.a2021.0081","article-title":"Elevated serum transaminases in patients with acute coronary syndromes: Do we need a revision of exclusion criteria for clinical trials?","volume":"30","author":"Jasiewicz","year":"2023","journal-title":"Cardiol J"},{"key":"2024091522265339000_14.9.e081293.18","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.5.815"},{"key":"2024091522265339000_14.9.e081293.19","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200528040-00006"},{"key":"2024091522265339000_14.9.e081293.20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.48817","article-title":"Acupuncture for the treatment of diarrhea-predominant irritable bowel syndrome: A pilot randomized clinical trial","volume":"5","author":"Qi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2024091522265339000_14.9.e081293.21","doi-asserted-by":"crossref","DOI":"10.1186\/s13020-023-00724-w","article-title":"Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: a randomized controlled pilot clinical trial","volume":"18","author":"Zhao","year":"2023","journal-title":"Chin Med"},{"key":"2024091522265339000_14.9.e081293.22","first-page":"344","article-title":"Statistical methods for clinical non-inferiority\/equivalence evaluation (in Chinese)","volume":"5","author":"Liu","year":"2000","journal-title":"Chin J Clin Pharmacol Ther"},{"key":"2024091522265339000_14.9.e081293.23","doi-asserted-by":"crossref","DOI":"10.3390\/nu14142921","article-title":"Litchi-derived polyphenol alleviates liver steatosis and gut dysbiosis in patients with non-alcoholic fatty liver disease: A randomized double-blinded, placebo-controlled study","volume":"14","author":"Jinato","year":"2022","journal-title":"Nutrients"},{"key":"2024091522265339000_14.9.e081293.24","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X16656735"},{"key":"2024091522265339000_14.9.e081293.25","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027050","article-title":"The efficacy and safety of acupuncture in nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials","volume":"100","author":"Chen","year":"2021","journal-title":"Medicine (Balt)"},{"key":"2024091522265339000_14.9.e081293.26","unstructured":"Zhao W , Xu E , Wang X , et al . n.d. Guidelines for traditional Chinese medicine diagnosis and treatment of non alcoholic fatty hepatitis (in Chinese). Chin J Integr Tradit West Med Liver Dis 32:1059\u201362."},{"key":"2024091522265339000_14.9.e081293.27","doi-asserted-by":"publisher","DOI":"10.1136\/aim.17.2.110"},{"key":"2024091522265339000_14.9.e081293.28","doi-asserted-by":"crossref","first-page":"620671","DOI":"10.1155\/2013\/620671","article-title":"Deqi sensation in placebo acupuncture: A crossover study on Chinese medicine students","volume":"2013","author":"Liang","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"2024091522265339000_14.9.e081293.29","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0b013e318213fefb"},{"key":"2024091522265339000_14.9.e081293.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9993.2001.01070.pp.x)"},{"key":"2024091522265339000_14.9.e081293.31","article-title":"Acupuncture improves the symptoms, intestinal microbiota, and inflammation of patients with mild to moderate Crohn\u2019s disease: A randomized controlled trial","volume":"45","author":"Bao","year":"2022","journal-title":"E Clin Med"},{"key":"2024091522265339000_14.9.e081293.32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.48817","article-title":"Acupuncture for the treatment of diarrhea-predominant irritable bowel syndrome: A pilot randomized clinical trial","volume":"5","author":"Qi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2024091522265339000_14.9.e081293.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.08.061"},{"key":"2024091522265339000_14.9.e081293.34","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.85"},{"key":"2024091522265339000_14.9.e081293.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0031-8"},{"key":"2024091522265339000_14.9.e081293.36","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1053\/j.gastro.2020.01.049","article-title":"Nonalcoholic fatty liver disease: Modulating gut microbiota to improve severity?","volume":"158","author":"Aron-Wisnewsky","year":"2020","journal-title":"Gastroenterology"},{"key":"2024091522265339000_14.9.e081293.37","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1854008"},{"key":"2024091522265339000_14.9.e081293.38","doi-asserted-by":"crossref","DOI":"10.3390\/nu9111220","article-title":"Nonalcoholic fatty liver disease is exacerbated in high-fat diet-fed gnotobiotic mice by colonization with the gut microbiota from patients with nonalcoholic steatohepatitis","volume":"9","author":"Chiu","year":"2017","journal-title":"Nutrients"},{"key":"2024091522265339000_14.9.e081293.39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29465"},{"key":"2024091522265339000_14.9.e081293.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0061-3"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-081293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T05:28:24Z","timestamp":1726464504000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-081293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,13]]},"published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1136\/bmjopen-2023-081293"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-081293","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}